Trial Profile
A open lable, descriptive study to determine safety and efficacy of entecavir in nucleos(t)ide-naive Black/African American patients with chronic hepatitis B (CHB).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record